Hologic, Inc. HOLX recently announced the receipt of FDA premarket approval (PMA) of ThinPrep Genesis processor for cytology processing and specimen transfer for downstream applications.

In a cluster-randomized trial conducted in 246 clinics in the Netherlands, ThinPrep was compared with conventional cytology for cervical cancer screening in 89,784 women aged 30-60 years (Obstet ...

The ThinPrep integrated imager was introduced and on display at the 35th European Congress of Cytology this week in Lisbon, Portugal. The integrated imager represents the latest innovation in ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the ThinPrep® Genesis processor for cytology slide and molecular test preparation has received a CE IVD mark ...

for the use of the ThinPrep Pap Test PreservCyt Solution vial as an approved sample type for its BD Onclarity HPV Assay. The PMA supplement would expand the sample claims that can be used in ...

The UT Southwestern team reported that the clear picture of molecular changes using the cytology suspended in the ThinPrep Pap test specimens could allow researchers to discover the risk ...

Women in the Greater Auckland area will be able to get a ThinPrep cervical smear test from their doctor at no extra charge from today. Previously, there was an additional charge from the doctor ...